• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含氮双膦酸盐对人上皮(Caco-2)细胞的影响,一种用于肠上皮的体外模型。

The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium.

作者信息

Twiss I M, Pas O, Ramp-Koopmanschap W, Den Hartigh J, Vermeij P

机构信息

Leiden University Medical Center, Department of Clinical Pharmacy, Leiden, The Netherlands.

出版信息

J Bone Miner Res. 1999 May;14(5):784-91. doi: 10.1359/jbmr.1999.14.5.784.

DOI:10.1359/jbmr.1999.14.5.784
PMID:10320527
Abstract

Nitrogen-containing bisphosphonates (N-PCP) are bisphosphonates with an increased antiresorptive potency. Aminobisphosphonates, N-PCPs with an amino group, can cause nonspecific gastrointestinal complaints. It is not known whether these side effects are specific for these bisphosphonates or for the whole class of N-PCPs. In this study, we investigated the effects of two aminobisphosphonates (pamidronate and alendronate) and a structurally similar N-PCP (olpadronate) and their three respective calcium complexes on the viability and the intracellular calcium concentration ([Ca2+]i) of cultured Caco-2 cells a model for intestinal epithelium. These cells were also examined for apoptosis or necrosis. In the presence of calcium, pamidronate and alendronate were toxic to the cells, with pamidronate being more toxic than alendronate. Olpadronate induced toxicity only at concentrations more than ten times higher than the toxic concentrations of pamidronate. In the absence of calcium definite signs of toxicity were observed only with pamidronate at clinically relevant concentrations. The complexes of pamidronate and alendronate with calcium were considerably less soluble than the olpadronate calcium complex. There were no signs of apoptosis. [Ca2+]i was transiently raised after treatment with the N-PCPs. Doses at which responses were seen were, respectively, 0.02 mM (pamidronate), 0.3 mM (alendronate), and 2 mM (olpadronate). The peak of response was slightly greater after pamidronate treatment than after alendronate or olpadronate, respectively. In conclusion pamidronate, either as an ion or as a calcium complex, is the most toxic of the bisphosphonates tested for Caco-2 cells. Alendronate was less toxic while olpadronate was the least toxic in presence of calcium. The solubility of the bisphosphonate complexes with calcium may account for these differences in toxicity.

摘要

含氮双膦酸盐(N - PCP)是一类抗吸收效力增强的双膦酸盐。氨基双膦酸盐是带有氨基的N - PCP,可引起非特异性胃肠道不适。目前尚不清楚这些副作用是这些双膦酸盐所特有的,还是整个N - PCP类药物共有的。在本研究中,我们研究了两种氨基双膦酸盐(帕米膦酸盐和阿仑膦酸盐)以及一种结构相似的N - PCP(奥帕膦酸盐)及其三种相应的钙络合物对培养的Caco - 2细胞(一种肠上皮细胞模型)的活力和细胞内钙浓度([Ca2 + ]i)的影响。还对这些细胞进行了凋亡或坏死检测。在有钙存在的情况下,帕米膦酸盐和阿仑膦酸盐对细胞有毒性,其中帕米膦酸盐的毒性比阿仑膦酸盐更强。奥帕膦酸盐仅在浓度高于帕米膦酸盐毒性浓度十倍以上时才诱导毒性。在无钙情况下,仅在临床相关浓度的帕米膦酸盐中观察到明确的毒性迹象。帕米膦酸盐和阿仑膦酸盐与钙的络合物的溶解度远低于奥帕膦酸盐钙络合物。未观察到凋亡迹象。用N - PCP处理后,[Ca2 + ]i短暂升高。出现反应的剂量分别为0.02 mM(帕米膦酸盐)、0.3 mM(阿仑膦酸盐)和2 mM(奥帕膦酸盐)。帕米膦酸盐处理后的反应峰值分别略高于阿仑膦酸盐或奥帕膦酸盐处理后的反应峰值。总之,对于Caco - 2细胞而言,帕米膦酸盐无论是作为离子还是作为钙络合物,都是所测试的双膦酸盐中毒性最强的。在有钙存在的情况下,阿仑膦酸盐毒性较小,而奥帕膦酸盐毒性最小。双膦酸盐与钙的络合物的溶解度可能解释了这些毒性差异。

相似文献

1
The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium.含氮双膦酸盐对人上皮(Caco-2)细胞的影响,一种用于肠上皮的体外模型。
J Bone Miner Res. 1999 May;14(5):784-91. doi: 10.1359/jbmr.1999.14.5.784.
2
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.氨基双膦酸盐可导致成骨细胞凋亡,并在体外抑制骨结节形成。
Calcif Tissue Int. 2008 Mar;82(3):191-201. doi: 10.1007/s00223-008-9104-y. Epub 2008 Feb 8.
3
Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.双膦酸盐与晚期糖基化终产物对成骨细胞的相反作用。
Eur J Pharmacol. 2008 Dec 14;600(1-3):140-7. doi: 10.1016/j.ejphar.2008.10.031. Epub 2008 Oct 21.
4
[Tolerability of oral bisphosponates in patients with osteoporosis and other osteopathies].[口服双膦酸盐在骨质疏松症和其他骨病患者中的耐受性]
Medicina (B Aires). 1997;57 Suppl 1:114-8.
5
Alendronate inhibits proliferation and invasion of human epidermoid carcinoma cells in vitro.
Anticancer Res. 2005 Jul-Aug;25(4):2655-60.
6
Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation.阿仑膦酸盐和帕米膦酸盐对培养的大鼠跖骨的影响:未能预防地塞米松诱导的生长迟缓。
Bone. 2008 Apr;42(4):702-9. doi: 10.1016/j.bone.2008.01.001. Epub 2008 Jan 16.
7
Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity.
Bone. 2001 Oct;29(4):336-43. doi: 10.1016/s8756-3282(01)00589-0.
8
A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.含氮双膦酸盐帕米膦酸、阿仑膦酸和奥帕膦酸对人体胃肠道影响的比较。
J Clin Pharmacol. 2006 Apr;46(4):483-7. doi: 10.1177/0091270006286781.
9
Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.阿仑膦酸盐和帕米膦酸盐磷酸钙骨水泥:凝固特性以及成骨细胞和破骨细胞的体外反应
J Inorg Biochem. 2009 Jan;103(1):101-6. doi: 10.1016/j.jinorgbio.2008.09.012. Epub 2008 Oct 1.
10
[Preclinical toxicology of bisphosphonates].[双膦酸盐类的临床前毒理学]
Medicina (B Aires). 1997;57 Suppl 1:93-100.

引用本文的文献

1
Etiopathogenesis of medication-related osteonecrosis of the jaws: a review.药物相关性颌骨坏死的病因发病机制:综述。
J Mol Med (Berl). 2024 Mar;102(3):353-364. doi: 10.1007/s00109-024-02425-9. Epub 2024 Feb 2.
2
Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.药物相关性颌骨坏死 (MRONJ) 与多发性骨髓瘤患者的 eNOS 多态性:单中心经验。
BMC Oral Health. 2021 May 18;21(1):272. doi: 10.1186/s12903-021-01634-9.
3
Pharmacology of bisphosphonates.双膦酸盐的药理学。
Br J Clin Pharmacol. 2019 Jun;85(6):1052-1062. doi: 10.1111/bcp.13867. Epub 2019 Feb 28.
4
Alendronate-induced unmasking or deterioration of coeliac disease: a case series.阿仑膦酸钠诱发的乳糜泻暴露或病情恶化:病例系列
Osteoporos Int. 2015 Jan;26(1):411-4. doi: 10.1007/s00198-014-2942-8. Epub 2014 Oct 28.
5
Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment.双膦酸盐相关颌骨坏死:病理生理学、危险因素及治疗的最新进展
Int J Dent. 2014;2014:471035. doi: 10.1155/2014/471035. Epub 2014 Sep 1.
6
Upper gastrointestinal tract transit times of tablet and drinkable solution formulations of alendronate: a bioequivalence and a quantitative, randomized study using video deglutition.阿仑膦酸钠片剂和口服液体制剂的上消化道转运时间:一项使用视频吞咽法的生物等效性和定量、随机研究。
Calcif Tissue Int. 2012 Nov;91(5):325-34. doi: 10.1007/s00223-012-9639-9. Epub 2012 Aug 26.
7
Effects of pamidronate on human alveolar osteoblasts in vitro.帕米膦酸盐对人牙槽成骨细胞的体外作用。
J Oral Maxillofac Surg. 2012 May;70(5):1081-92. doi: 10.1016/j.joms.2011.05.002.
8
Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.逆转双膦酸盐对原代人口腔成纤维细胞的细胞效应的新型疗法。
J Oral Maxillofac Surg. 2011 Oct;69(10):2564-78. doi: 10.1016/j.joms.2011.03.005. Epub 2011 Jul 31.
9
Potential pathophysiological mechanisms in osteonecrosis of the jaw.颌骨骨坏死的潜在病理生理学机制。
Ann N Y Acad Sci. 2011 Feb;1218:62-79. doi: 10.1111/j.1749-6632.2010.05835.x.
10
The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.在去卵巢骨质疏松大鼠模型中,阿法骨化醇与利塞膦酸盐联合治疗通过影响材料特性来改善腰椎的力学性能。
BMC Musculoskelet Disord. 2009 Jun 15;10:66. doi: 10.1186/1471-2474-10-66.